Healthy volunteers needed to test new drug interactions
NCT ID NCT07374224
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study looks at how two common drugs—itraconazole (a fungus treatment) and rifampin (an antibiotic)—change the way the body processes rocbrutinib, an experimental medicine. About 28 healthy adults will take rocbrutinib alone and then with each other drug to measure blood levels and safety. The goal is to gather information, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL PHARMACOLOGY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University Third Hospital
RECRUITINGBeijing, Beijing Municipality, 100070, China